The Hill (4/2, Savransky) says, “A webpage that focused on breast cancer was reportedly scrubbed from the website of the Department of Health and Human Services’ (HHS) Office on Women’s Health (OWH),” according to an analysis conducted by the Sunlight Foundation’s Web Integrity Project. An HHS spokesperson explained that “the page was removed Dec. 6, 2017 ‘because content was not mobile-friendly and very rarely used.’” The analysis concluded that some of “the material removed is information about provisions of the Affordable Care Act that require coverage of no-cost breast cancer screenings for certain women, as well as links to a free cancer screening program administered by the Centers for Disease Control and Prevention (CDC).”
Newsweek (4/2, Lee) reports that “content about mammogram breast cancer screening remains” on the website, but “informational pages and factsheets about the disease, including symptoms, treatment, risk factors, and public no- or low-cost cancer screening programs, have been entirely removed,” the Sunlight Foundation said.
Nancy Brinker, founder of Susan G. Komen, and Eric Rosenthal, an advocate and writer on breast cancer issues, write in The Hill (4/2) that “it is especially disturbing” that HHS’ Office on Women’s Health removed a webpage dedicated to breast cancer and other reproductive health information last December. The duo write, “There is a great disconnect when there is an increasing need for access to information, early detection, and treatment of breast cancer, especially among underserved populations, and when available resources are curtailed because a government agency claims it wasn’t ‘mobile friendly and very rarely used.’”
Aunt Minnie (4/2) reports that “although breast implants lowered the cancer detection rate on screening mammography, they increased the likelihood that cancers would be detected at smaller sizes on examinations, according to a study published in the April issue of Plastic and Reconstructive Surgery.” Researchers examined “the breast cancers of 48 patients with implants and 302 without them,” finding the breast cancers detected in the women with implants “were an average of 0.5 cm smaller than those in the women without implants.”
The Radiology Business Journal (3/30, Walter) reported that research suggests “digital breast tomosynthesis (DBT) can help radiologists detect more architectural distortion (AD) lesions than 2D mammography alone.” The findings were published in Radiology.
The Radiology Business Journal (3/30, Walter) reported that research indicates that “two out of three women want a biopsy performed if a radiologist determines there is any chance of breast cancer.” The study “also found that women overestimate the risk of breast cancer when follow-up imaging or biopsy is recommended for low-risk mammographic abnormalities.” The findings were published in the Journal of the American College of Radiology.
Aunt Minnie (3/30, Yee) reports, “More than 80% of screening breast MRI exams are performed on women for whom the test is not necessarily recommended – that is, women with a lifetime risk for the disease of less than 20%,” according to a study published in the Journal of General Internal Medicine. “Breast MRI use that is not concordant with guidelines...poses distinct challenges to effective resource allocation in breast cancer screening,” the researchers wrote. The piece notes, “Screening breast MRI is currently recommended for women with 20% or greater lifetime breast cancer risk by the American Cancer Society (ACS), the American College of Radiology (ACR), and the Society of Breast Imaging (SBI).”